The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis
Abstract
Antioxidant antidiabetic drugs may promote tumor metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480 · cited 1×
“Because expression of NRF2 is primarily controlled at the protein level by the KEAP1-containing E3 ubiquitin ligase complex through ubiquitination and subsequent proteasomal degradation of NRF2 (23), we next assessed the ubiquitination and half-life of NRF2.”
BackgroundSelf-citationThe emerging role of the Nrf2–Keap1 signaling pathway in cancer
Jaramillo, M. C., & Zhang, D. D. (2013) · Genes & Development · doi:10.1101/gad.225680.113 · Cited by 1,297
Self-citationOxidative stress inhibits distant metastasis by human melanoma cells
Piskounova, E., Agathocleous, M., Murphy, M. M., Hu, Z., Huddlestun, S. E., Zhao, Z., Leitch, A. M., Johnson, T. M., DeBerardinis, R. J., & Morrison, S. J. (2015) · Nature · doi:10.1038/nature15726 · Cited by 1,269
Lactate: A Metabolic Key Player in Cancer
Hirschhaeuser, F., Sattler, U. G. A., & Mueller-Klieser, W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1457 · Cited by 1,090
Diabetes and Cancer: A Consensus Report
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20078 · Cited by 1,055
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Suh, J. H., Shenvi, S. V., Dixon, B. M., Liu, H., Jaiswal, A. K., Liu, R.-M., & Hagen, T. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400282101 · Cited by 772
Zannad, F., Cannon, C. P., Cushman, W. C., Bakris, G. L., Menon, V., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., Wilson, C., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62225-x · Cited by 757
Scirica, B. M., Braunwald, E., Raz, I., Cavender, M. A., Morrow, D. A., Jarolim, P., Udell, J. A., Mosenzon, O., Im, K., Umez-Eronini, A. A., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.010389 · Cited by 725
Chowdhry, S., Zhang, Y., McMahon, M., Sutherland, C., Cuadrado, A., & Hayes, J. D. (2013) · Oncogene · doi:10.1038/onc.2012.388 · Cited by 657
Antioxidants can increase melanoma metastasis in mice
Le Gal, K., Ibrahim, M. X., Wiel, C., Sayin, V. I., Akula, M. K., Karlsson, C., Dalin, M. G., Akyürek, L. M., Lindahl, P., Nilsson, J., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad3740 · Cited by 632 · cited 1×
“Our results support the notion that ROS limit distant metastasis and that antioxidants accelerate migration and invasion of cancer cells (35, 36).”
ResultHandelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone
Lewis, J. D., Ferrara, A., Peng, T., Hedderson, M., Bilker, W. B., Quesenberry, C. P., Vaughn, D. J., Nessel, L., Selby, J., & Strom, B. L. (2011) · Diabetes Care · doi:10.2337/dc10-1068 · Cited by 625
Bergenstal, R. M., Wysham, C., MacConell, L., Malloy, J., Walsh, B., Yan, P., Wilhelm, K., Malone, J., & Porter, L. E. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60590-9 · Cited by 608
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Rosenstock, J., Brazg, R., Andryuk, P. J., Lu, K., & Stein, P. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.10.007 · Cited by 514
Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
Zheng, H., Whitman, S. A., Wu, W., Wondrak, G. T., Wong, P. K., Fang, D., & Zhang, D. D. (2011) · Diabetes · doi:10.2337/db11-0807 · Cited by 507
Self-citationLavalle-González, F. J., Januszewicz, A., Davidson, J., Tong, C., Qiu, R., Canovatchel, W., & Meininger, G. (2013) · Diabetologia · doi:10.1007/s00125-013-3039-1 · Cited by 492
Oxidative Stress in Diabetic Nephropathy
Kashihara, N., Haruna, Y., K. Kondeti, V., & S. Kanwar, Y. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710793348581 · Cited by 464
Khanna, C. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh261 · Cited by 463
Roden, M., Weng, J., Eilbracht, J., Delafont, B., Kim, G., Woerle, H. J., & Broedl, U. C. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70084-6 · Cited by 450
Bosi, E., Camisasca, R. P., Collober, C., Rochotte, E., & Garber, A. J. (2007) · Diabetes Care · doi:10.2337/dc06-1732 · Cited by 447
McMahon, M., Lamont, D. J., Beattie, K. A., & Hayes, J. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007387107 · Cited by 443
DeFronzo, R. A., Hissa, M. N., Garber, A. J., Luiz Gross, J., Yuyan Duan, R., Ravichandran, S., Chen, R. S., & for the Saxagliptin 014 Study Group (2009) · Diabetes Care · doi:10.2337/dc08-1984 · Cited by 416
Cui, X., Zuo, P., Zhang, Q., Li, X., Hu, Y., Long, J., Packer, L., & Liu, J. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20845 · Cited by 408
Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes
Fonseca, V., Schweizer, A., Albrecht, D., Baron, M. A., Chang, I., & Dejager, S. (2007) · Diabetologia · doi:10.1007/s00125-007-0633-0 · Cited by 369
Gallwitz, B., Rosenstock, J., Rauch, T., Bhattacharya, S., Patel, S., von Eynatten, M., Dugi, K. A., & Woerle, H.-J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60691-6 · Cited by 343
Russell-Jones, D., Cuddihy, R. M., Hanefeld, M., Kumar, A., González, J. G., Chan, M., Wolka, A. M., Boardman, M. K., & on behalf of the DURATION-4 Study Group (2012) · Diabetes Care · doi:10.2337/dc11-1107 · Cited by 339
Barreira da Silva, R., Laird, M. E., Yatim, N., Fiette, L., Ingersoll, M. A., & Albert, M. L. (2015) · Nature Immunology · doi:10.1038/ni.3201 · Cited by 337
Does diabetes therapy influence the risk of cancer?
Smith, U., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1441-5 · Cited by 316
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
Vilsbøll, T., Rosenstock, J., Yki‐Järvinen, H., Cefalu, W. T., Chen, Y., Luo, E., Musser, B., Andryuk, P. J., Ling, Y., Kaufman, K. D., et al. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01173.x · Cited by 305
Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
Sadeghi, N., Abbruzzese, J. L., Yeung, S.-C. J., Hassan, M., & Li, D. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2994 · Cited by 305
Del Prato, S., Barnett, A. H., Huisman, H., Neubacher, D., Woerle, H. ‐., & Dugi, K. A. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01350.x · Cited by 299
Jadzinsky, M., Pfützner, A., Paz‐Pacheco, E., Xu, Z., Allen, E., Chen, R., & CV181‐039 Investigators (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01056.x · Cited by 296
NRF2 Blockade Suppresses Colon Tumor Angiogenesis by Inhibiting Hypoxia-Induced Activation of HIF-1α
Kim, T.-H., Hur, E.-G., Kang, S.-J., Kim, J.-A., Thapa, D., Lee, Y. M., Ku, S. K., Jung, Y., & Kwak, M.-K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3007 · Cited by 292
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes
Rosenstock, J., Aguilar-Salinas, C., Klein, E., Nepal, S., List, J., Chen, R., & for the CV181-011 Study Investigators (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903178735 · Cited by 288
High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
Jiang, T., Chen, N., Zhao, F., Wang, X.-J., Kong, B., Zheng, W., & Zhang, D. D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0713 · Cited by 286 · cited 2×
“Many studies, including ours, showed that NRF2 expression was increased in various human cancers (38), and this aberrant accumulation of NRF2 correlated with oncogene expression, cell proliferation, and cancer chemoresistance (22, 39).”
BackgroundNauck, M., Weinstock, R. S., Umpierrez, G. E., Guerci, B., Skrivanek, Z., & Milicevic, Z. (2014) · Diabetes Care · doi:10.2337/dc13-2761 · Cited by 284
Sauvé, M., Ban, K., Momen, M. A., Zhou, Y.-Q., Henkelman, R. M., Husain, M., & Drucker, D. J. (2010) · Diabetes · doi:10.2337/db09-0955 · Cited by 264
Raz, I., Chen, Y., Wu, M., Hussain, S., Kaufman, K. D., Amatruda, J. M., Langdon, R. B., Stein, P. P., & Alba, M. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x260925 · Cited by 260
Forst, T., Guthrie, R., Goldenberg, R., Yee, J., Vijapurkar, U., Meininger, G., & Stein, P. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12273 · Cited by 255
Pratley, R., Nauck, M., Bailey, T., Montanya, E., Cuddihy, R., Filetti, S., Garber, A., Thomsen, A. B., Hartvig, H., Davies, M., et al. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02656.x · Cited by 253
Piccinni, C., Motola, D., Marchesini, G., & Poluzzi, E. (2011) · Diabetes Care · doi:10.2337/dc10-2412 · Cited by 239
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency
Chan, J. C. N., Scott, R., Arjona Ferreira, J. C., Sheng, D., Gonzalez, E., Davies, M. J., Stein, P. P., Kaufman, K. D., Amatruda, J. M., & Williams‐Herman, D. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00914.x · Cited by 238
Garber, A. J., Foley, J. E., Banerji, M. A., Ebeling, P., Gudbjörnsdottir, S., Camisasca, R. ‐., Couturier, A., & Baron, M. A. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00859.x · Cited by 230
Kang, R., Tang, D., Schapiro, N. E., Loux, T., Livesey, K. M., Billiar, T. R., Wang, H., Van Houten, B., Lotze, M. T., & Zeh, H. J. (2014) · Oncogene · doi:10.1038/onc.2012.631 · Cited by 230
Self-citationAhrén, B., Johnson, S. L., Stewart, M., Cirkel, D. T., Yang, F., Perry, C., & Feinglos, M. N. (2014) · Diabetes Care · doi:10.2337/dc14-0024 · Cited by 228
DeFronzo, R. A., Fleck, P. R., Wilson, C. A., Mekki, Q., & on behalf of the Alogliptin Study 010 Group (2008) · Diabetes Care · doi:10.2337/dc08-1035 · Cited by 227
Cui, X., Zuo, P., Zhang, Q., Li, X., Hu, Y., Long, J., Packer, L., & Liu, J. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20899 · Cited by 221
Long-Term Safety and Efficacy of Empagliflozin, Sitagliptin, and Metformin
Ferrannini, E., Berk, A., Hantel, S., Pinnetti, S., Hach, T., Woerle, H. J., & Broedl, U. C. (2013) · Diabetes Care · doi:10.2337/dc13-0663 · Cited by 214
Abstract #100: Acth-Secreting Pheochromocytoma
Kalia-Reynolds, M., Giordano, J., Kalia-Reynolds, I., & Houston, C. (2015) · Endocrine Practice · doi:10.1016/s1530-891x(20)42300-6 · Cited by 208
Nauck, M. A., Ellis, G. C., Fleck, P. R., Wilson, C. A., Mekki, Q., & for the Alogliptin Study 008 Group (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01933.x · Cited by 205
Rosenstock, J., Rendell, M. S., Gross, J. L., Fleck, P. R., Wilson, C. A., & Mekki, Q. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01124.x · Cited by 189
Barnett, A. H., Huisman, H., Jones, R., von Eynatten, M., Patel, S., & Woerle, H.-J. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61500-7 · Cited by 183
A Meta-analysis of Randomized Clinical Trials
Crescenzi, G., Landoni, G., Biondi‐Zoccai, G., Pappalardo, F., Nuzzi, M., Bignami, E. G., Fochi, O., Maj, G., Ranucci, M., & Zangrillo, A. (2008) · Cited by 181
Arechavaleta, R., Seck, T., Chen, Y., Krobot, K. J., O’Neill, E. A., Duran, L., Kaufman, K. D., Williams‐Herman, D., & Goldstein, B. J. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01334.x · Cited by 169
Endothelial Cell HIF-1α and HIF-2α Differentially Regulate Metastatic Success
Branco-Price, C., Zhang, N., Schnelle, M., Evans, C., Katschinski, D. M., Liao, D., Ellies, L., & Johnson, R. S. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.11.017 · Cited by 168
Aschner, P. J., Katzeff, H. L., Guo, H., Sunga, S., Williams‐Herman, D., Kaufman, K. D., Goldstein, B. J., & for the Sitagliptin Study 049 Group (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01187.x · Cited by 166
Pratley, R. E., Kipnes, M. S., Fleck, P. R., Wilson, C., Mekki, Q., & Alogliptin Study 007 Group (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.01016.x · Cited by 162
Arjona Ferreira, J. C., Marre, M., Barzilai, N., Guo, H., Golm, G. T., Sisk, C. M., Kaufman, K. D., & Goldstein, B. J. (2013) · Diabetes Care · doi:10.2337/dc12-1365 · Cited by 159
Stenlöf, K., Cefalu, W. T., Kim, K.-A., Jodar, E., Alba, M., Edwards, R., Tong, C., Canovatchel, W., & Meininger, G. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.850066 · Cited by 158
Fujii, S., Sawa, T., Ihara, H., Tong, K. I., Ida, T., Okamoto, T., Ahmed, K. A., Ishima, Y., Motohashi, H., Yamamoto, M. P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.145441 · Cited by 152
Haak, T., Meinicke, T. W., Jones, R., Weber, S., von Eynatten, M., & Woerle, H. J. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01590.x · Cited by 145
Barzilai, N., Guo, H., Mahoney, E. M., Caporossi, S., Golm, G. T., Langdon, R. B., Williams‐Herman, D., Kaufman, K. D., Amatruda, J. M., Goldstein, B. J., et al. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.568059 · Cited by 139
Pratley, R. E., Reusch, J. E. B., Fleck, P. R., Wilson, C., Mekki, Q. A., & on behalf of the Alogliptin Study 009 Group (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903156111 · Cited by 138
Ferreira, J. C. A., Corry, D. B., Mogensen, C. E., Sloan, L. A., Xu, L., Golm, G. T., Gonzalez, E. J., Davies, M. J., Kaufman, K. D., & Goldstein, B. J. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.11.043 · Cited by 136
Nowicki, M. P., Rychlík, I., Haller, H. G., Warren, M., Suchower, L. J., Gause‐Nilsson, I. A. M., & Schützer, K.-M. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02812.x · Cited by 134
Fritzmann, J., Morkel, M., Besser, D., Budczies, J., Kosel, F., Brembeck, F. H., Stein, U., Fichtner, I., Schlag, P. M., & Birchmeier, W. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.041 · Cited by 129
Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes
Meyskens, F. L., McNulty, S. E., Buckmeier, J. A., Tohidian, N. B., Spillane, T. J., Kahlon, R. S., & Gonzalez, R. I. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00650-5 · Cited by 126
Ji, X., Wang, H., Zhu, J., Zhu, L., Pan, H., Li, W., Zhou, Y., Cong, Z., Yan, F., & Chen, S. (2013) · International Journal of Cancer · doi:10.1002/ijc.28699 · Cited by 122
Self-citationDoses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
Mannucci, E., Monami, M., Balzi, D., Cresci, B., Pala, L., Melani, C., Lamanna, C., Bracali, I., Bigiarini, M., Barchielli, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0476 · Cited by 121
Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma
Chuma, M., Sakamoto, M., Yasuda, J., Fujii, G., Nakanishi, K., Tsuchiya, A., Ohta, T., Asaka, M., & Hirohashi, S. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.018 · Cited by 117
Aschner, P. J., Chan, J. C. N., Owens, D. R., Picard, S., Wang, E., Dain, M., Pilorget, V., Echtay, A. S., & Fonseca, V. A. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60439-5 · Cited by 115
Monami, M., Dicembrini, I., & Mannucci, E. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12176 · Cited by 112
Rosenstock, J., Inzucchi, S. E., Seufert, J., Fleck, P. R., Wilson, C., & Mekki, Q. A. (2010) · Diabetes Care · doi:10.2337/dc10-0159 · Cited by 112
Zhang, G., Panigrahy, D., Hwang, S. H., Yang, J., Mahakian, L. M., Wettersten, H. I., Liu, J., Wang, Y., Ingham, E. S., Tam, S. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410432111 · Cited by 97
Self-citationLeiter, L. A., Carr, M. C., Stewart, M. W., Jones-Leone, A. R., Scott, R., Yang, F., & Handelsman, Y. (2014) · Diabetes Care · doi:10.2337/dc13-2855 · Cited by 97
Tao, S., Zheng, Y., Lau, A., Jaramillo, M. C., Chau, B. T., Lantz, R. C., Wong, P. K., Wondrak, G. T., & Zhang, D. D. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5117 · Cited by 95
Self-citationGöke, B., Hershon, K. S., Kerr, D. E., Pascual, A. C., Schweizer, A., Foley, J. E., Shao, Q., & Dejager, S. (2008) · Hormone and Metabolic Research · doi:10.1055/s-0028-1082334 · Cited by 93
Inhibition of Breast Cancer Metastases by a Novel Inhibitor of TGFβ Receptor 1
Fang, Y., Chen, Y., Yu, L., Zheng, C., Ya, Q., Li, Z., Yang, Z., Zhang, Y., Shi, T., Luo, J., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs485 · Cited by 92
Rosenstock, J., Wilson, C., & Fleck, P. R. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12102 · Cited by 91
Göke, B., Gallwitz, B., Eriksson, J. G., Hellqvist, Å., & Gause‐Nilsson, I. A. M. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12119 · Cited by 90
Bosi, E., Ellis, G. C., Wilson, C. A., & Fleck, P. R. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01463.x · Cited by 88
Long, M., Tao, S., Rojo de la Vega, M., Jiang, T., Wen, Q., Park, S. L., Zhang, D. D., & Wondrak, G. T. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0359 · Cited by 86
Self-citationGjyshi, O., Bottero, V., Veettil, M. V., Dutta, S., Singh, V. V., Leela, C., & Chandran, B. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004460 · Cited by 85
Shen, T., Jiang, T., Long, M., Chen, J., Ren, D.-M., Wong, P. K., Chapman, E., Zhou, B., & Zhang, D. D. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6074 · Cited by 84
Self-citationSeino, Y., Fujita, T., Hiroi, S., Hirayama, M., & Kaku, K. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.599371 · Cited by 84
Skrivanek, Z., Gaydos, B. L., Chien, J. Y., Geiger, M. J., Heathman, M. A., Berry, S. M., Anderson, J. H., Forst, T. M., Miličević, Z., & Berry, D. A. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12305 · Cited by 78
Lu, D., Yeh, W., Huang, S.-M., Tang, C., Lin, H., & Chou, S.-J. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos262 · Cited by 76
Yang, W., Guan, Y., Shentu, Y., Li, Z., Johnson‐Levonas, A. O., Engel, S. S., Kaufman, K. D., Goldstein, B. J., & Alba, M. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2012.00213.x · Cited by 75
Christoforides, C., Rainero, E., Brown, K., Norman, J. C., & Toker, A. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.08.008 · Cited by 71
Barnett, A. H., Patel, S., Harper, R., Toorawa, R., Thiemann, S., von Eynatten, M., & Woerle, H. J. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12011 · Cited by 71
Schernthaner, G., Durán-Garcia, S., Hanefeld, M., Langslet, G., NISKANEN, L. K., Östgren, C. J., Malvolti, E., & Hardy, E. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12461 · Cited by 67
Hollander, P. L., Li, J., Frederich, R. C., Allen, E., Chen, R. K., & CV181013 Investigators (2011) · Diabetes and Vascular Disease Research · doi:10.1177/1479164111404575 · Cited by 67
Frederich, R. C., McNeill, R., Berglind, N., Fleming, D., & Chen, R. K. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-36 · Cited by 66
Chacra, A. R., Tan, G. H., Ravichandran, S., List, J. F., Chen, R. K., & CV181040 Investigators (2011) · Diabetes and Vascular Disease Research · doi:10.1177/1479164111404574 · Cited by 62
Bunck, M. C. M., Poelma, M., Eekhoff, E. M. W., Schweizer, A., Heine, R. J., Nijpels, G., Foley, J. E., & Diamant, M. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00168.x · Cited by 60
Barnett, A. H., Charbonnel, B. H., Li, J., Donovan, M., Fleming, D., & Iqbal, N. (2013) · Clinical Drug Investigation · doi:10.1007/s40261-013-0107-8 · Cited by 60
Laakso, M., Rosenstock, J., Groop, P., Barnett, A. H., Gallwitz, B., Hehnke, U., Tamminen, I., Patel, S. D., von Eynatten, M., & Woerle, H. (2015) · Diabetes Care · doi:10.2337/dc14-1684 · Cited by 55
Rosenstock, J., Niggli, M., & Maldonado‐Lutomirsky, M. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.01021.x · Cited by 54
Olansky, L., Reasner, C. A., Seck, T. L., Williams‐Herman, D., Chen, M., Terranella, L., Mehta, A., Kaufman, K. D., & Goldstein, B. J. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01416.x · Cited by 54
Fonseca, V. A., Staels, B., Morgan, J. D., Shentu, Y., Golm, G. T., Johnson‐Levonas, A. O., Kaufman, K. D., Goldstein, B. J., & Steinberg, H. O. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.09.007 · Cited by 51
Bajaj, M., Gilman, R. E., Patel, S., Kempthorne‐Rawson, J., Lewis-D’Agostino, D. J., & Woerle, H. J. (2014) · Diabetic Medicine · doi:10.1111/dme.12495 · Cited by 48
Bergenstal, R. M., Forti, A. C. E., Chiasson, J., Woloschak, M., Boldrin, M. N., & Balena, R. (2012) · Diabetes Therapy · doi:10.1007/s13300-012-0013-8 · Cited by 48
Wainstein, J., Katz, L., Engel, S. S., Xu, L., Golm, G. T., Hussain, S., O’Neill, E. A., Kaufman, K. D., & Goldstein, B. J. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01530.x · Cited by 48
Dobs, A. S., Goldstein, B. J., Aschner, P. J., Horton, E. S., Umpierrez, G. E., DURAN, L., HILL, J. S., Chen, Y., Golm, G. T., Langdon, R. B., et al. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2012.00223.x · Cited by 44
Diabetes treatments and cancer risk: the importance of considering aspects of drug exposure
Walker, J. J., Johnson, J. A., & Wild, S. H. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70028-7 · Cited by 38
Yang, X., Zhao, H., Sui, Y., Ronald, C. W., So, W. Y., Ko, G. T. C., Kong, A. P. S., Ozaki, R., Yeung, C. Y., Xu, G., et al. (2009) · Diabetes · doi:10.2337/db09-0105 · Cited by 37
Nakatani, K., Kurose, T., Hyo, T., Watanabe, K., Yabe, D., Kawamoto, T., & Seino, Y. (2012) · Diabetes Therapy · doi:10.1007/s13300-012-0014-7 · Cited by 36
Michikoshi, H., Nakamura, T., Sakai, K., Suzuki, Y., Adachi, E., Matsugo, S., & Matsumoto, K. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.008 · Cited by 36
Genetic polymorphism in the NRF2 gene as a prognosis marker for cancer chemotherapy
Ishikawa, T. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00383 · Cited by 32
Hartley, P., Shentu, Y., Betz-Schiff, P., Golm, G. T., Sisk, C. M., Engel, S. S., & Shankar, R. R. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0271-z · Cited by 31
Hermans, M. P., Delibaşı, T., Farmer, I., Lohm, L., Maheux, P., Piatti, P., Malvolti, E., Jörgens, S., & Charbonnel, B. H. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.735646 · Cited by 30
Seck, T. L., Engel, S. S., Williams‐Herman, D., Sisk, C. M., Golm, G. T., Wang, H., Kaufman, K. D., & Goldstein, B. J. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.03.006 · Cited by 22
Self-citation
Cited by
ROS in cancer therapy: the bright side of the moon
Perillo, B., Di Donato, M., Pezone, A., Di Zazzo, E., Giovannelli, P., Galasso, G., Castoria, G., & Migliaccio, A. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0384-2 · Cited by 2,176
The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis
Yamamoto, M., Kensler, T. W., & Motohashi, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2017 · Cited by 1,968
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791
NRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672
Self-citationThe Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
Xie, Y., Zhu, S., Song, X., Sun, X., Fan, Y., Liu, J., Zhong, M., Yuan, H., Zhang, L., Billiar, T. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.055 · Cited by 952
Self-citation
Metadata
- Authors
- Wang, H., Liu, X., Long, M., Huang, Y., Zhang, L., Zhang, R., Zheng, Y., Liao, X., Wang, Y., Liao, Q., Li, W., Tang, Z., Tong, Q., Wang, X., Fang, F., de la Vega, M. R., Ouyang, Q., Zhang, D. D., Yu, S., & Zheng, H.
- Venue
- Science Translational Medicine
- Published
- 2016-04-13
- Volume
- 8
- Issue
- 334
- Pages
- 334ra51-334ra51
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2335994272
- Cited by
- 286
- References
- 115
- FWCI
- 15.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.